AI assistant
ELUTIA INC. — Director's Dealing 2022
Sep 12, 2022
34697_dirs_2022-09-12_eb9dbc40-20bb-4771-95b1-3c9d35a89924.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2022-09-08
Reporting Person: Ferguson Matthew (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-08 | Class A Common Stock | M | 13874 | — | Acquired | 22015 | Direct |
| 2022-09-08 | Class A Common Stock | F | 4798 | $7.30 | Disposed | 17217 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-08 | Restricted Stock Units | $ | M | 13874 | Disposed | Class A Common Stock (13874) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2: Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
F3: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F4: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.